Please note that Virolens may not be available in all countries due to local regulatory authority approvals.
Certifications are currently underway in most geographies and are being managed by our local distributor network.
Identifying and screening COVID-19 patients quickly and effectively is key to getting the world moving again. Virolens is a rapid screening system that can be used at almost any location - airports, sporting events, schools, theatres, retail and offices.
Virolens allows people to get on with their everyday lives safe in the knowledge they are in a COVID-free environment.
The Virolens system is a screening device that combines holographic microscopy with artificial intelligence (AI) to detect SARS-CoV-2, the virus that causes COVID-19 disease. Virolens is constructed to the highest standards, designed and manufactured in the UK.
The Virolens® system uses a mouth swab, which is placed inside a cartridge and inserted into the system. The Virolens system is a portable floor-standing device.
Inside the Virolens® system is a holographic microscope designed to look at nano-scale structures. Light is projected onto the slide creating identifiable diffraction patterns.
The holographic image data is analysed using AI to identify the unique pattern of the virus from other cells very quickly.
The Virolens® system is completely self-contained and can give a yes/no result in around 20 seconds with the whole process taking about 1 minute.
A new application of existing technologies
This is a brand-new screening device which combines microscopic holographic imaging and artificial intelligence (AI) software technology.
Quick and easy
The system does not require a trained biologist to determine the results. It takes around 20 seconds to get a yes/no result.
Virolens has a 97.3% sensitivity and 99.7% specificity.
The samples from the screening process are collected and sanitised prior to recycling.
Able to collect anonymised data
Future proof software
Applicable to other diseases
Founded in 2010, iAbra's focus is deriving utility from the ever-growing amounts of sensor data in the world.
Artificial Intelligence is moving from the cloud to embedded applications.This is enabling a wide range of use cases including automotive, defence, manufacturing, healthcare and agriculture.
Machine Learning ecosystems have been built mostly on GPUs for the cloud, where neural networks are generally very large and inefficient. These cloud-based neural networks and power-hungry GPUs make the AI use cases requiring embedded inference more difficult or impossible to engineer. The FPGA's efficiency and low power consumption are better able to deliver embedded applications.
iAbra's tools ensure that efficient neural networks are created and optimised for embedded FPGA silicon, delivering low power AI inference for a variety of applications.
TT Electronics is a global provider of engineered electronics for performance critical applications. With around 5,000 employees operating from 30 key locations around the world, TT designs and manufactures a wide range of electronics for sensing, power management and connectivity primarily for applications in the industrial, medical and aerospace and defence sectors.
KeyOptions is the iAbra appointed Master agent for Virolens In Asia Pacific, Latin America Turkey & Eurasia and parts of Africa. Whilst KeyOptions is bringing the Virolens solution to market, our core focus is to provide some of our more traditional services around the Virolens solution. Over the coming months we will be announcing:
- Consulting services
- Systems integration into existing environments
- HealthKeyID to manage Virolens and other testing
- Our Assets-in-Motion solution to better manage Virolens machines, accessories, and other data analytics.
- Customised App development for clients specific needs
- Managed services
- We see a whole new eco-system being built around the Virolens system on the successful introduction of the system
Please contact us at firstname.lastname@example.org if you would like any further information on using Virolens in your environment.
Please note that Virolens may not be available, or be able to be advertised in all countries due to local regulatory authority approvals.
Certifications are currently underway in most geographies and are being managed by our distributor network.
Currently, Virolens is not approved for advertising or for sale in Australia
Please contact email@example.com for country availability